Creative Medical Technology Holdings Future Growth
Future criteria checks 3/6
Creative Medical Technology Holdings is forecast to grow earnings and revenue by 72.7% and 86.8% per annum respectively while EPS is expected to grow by 63.3% per annum.
Key information
72.7%
Earnings growth rate
63.3%
EPS growth rate
Biotechs earnings growth | 28.4% |
Revenue growth rate | 86.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 13 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -6 | N/A | N/A | 1 |
12/31/2025 | N/A | -4 | N/A | N/A | 1 |
12/31/2024 | N/A | -5 | N/A | N/A | 1 |
9/30/2024 | 0 | -5 | -5 | -5 | N/A |
6/30/2024 | 0 | -6 | -6 | -6 | N/A |
3/31/2024 | 0 | -5 | -5 | -5 | N/A |
12/31/2023 | 0 | -5 | -8 | -8 | N/A |
9/30/2023 | 0 | -10 | -10 | -10 | N/A |
6/30/2023 | 0 | -9 | -9 | -9 | N/A |
3/31/2023 | 0 | -10 | -10 | -10 | N/A |
12/31/2022 | 0 | -10 | -8 | -8 | N/A |
9/30/2022 | 0 | -8 | -5 | -5 | N/A |
6/30/2022 | 0 | -9 | -5 | -5 | N/A |
3/31/2022 | 0 | -10 | -3 | -3 | N/A |
12/31/2021 | 0 | 19 | -2 | -2 | N/A |
9/30/2021 | 0 | -16 | -1 | -1 | N/A |
6/30/2021 | 0 | -13 | -1 | -1 | N/A |
3/31/2021 | 0 | -12 | -1 | -1 | N/A |
12/31/2020 | 0 | -36 | -1 | 0 | N/A |
9/30/2020 | 0 | -3 | -1 | -1 | N/A |
6/30/2020 | 0 | -6 | -1 | -1 | N/A |
3/31/2020 | 0 | -4 | -1 | -1 | N/A |
12/31/2019 | 0 | -8 | -1 | -1 | N/A |
9/30/2019 | 0 | -1 | -1 | -1 | N/A |
6/30/2019 | 0 | -1 | -1 | -1 | N/A |
3/31/2019 | 0 | -7 | -1 | -1 | N/A |
12/31/2018 | 0 | -14 | -1 | -1 | N/A |
9/30/2018 | 0 | -17 | -1 | -1 | N/A |
6/30/2018 | 0 | -16 | N/A | -1 | N/A |
3/31/2018 | 0 | -10 | N/A | -1 | N/A |
12/31/2017 | 0 | -3 | N/A | -1 | N/A |
9/30/2017 | N/A | -1 | N/A | -1 | N/A |
6/30/2017 | N/A | -2 | N/A | -1 | N/A |
3/31/2017 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CELZ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: CELZ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CELZ is expected to become profitable in the next 3 years.
Revenue vs Market: CELZ is forecast to have no revenue next year.
High Growth Revenue: CELZ is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CELZ's Return on Equity is forecast to be high in 3 years time